TABLE 4.
Results of HGE serology for study group I patients with physician-diagnosed early Lyme disease
Result | No. of samples reactive for the following antibody/no. of samples examined (%):
|
|||||||
---|---|---|---|---|---|---|---|---|
IgM
|
IgG
|
|||||||
IFA result | EIA result | WB result | Both tests | IFA result | EIA result | WB result | Both tests | |
Positive | 35/139 (25.2) | 19/35 (54.2) | 19/139 (13.7) | 7/139 (5.0) | 7/7 (100) | 7/139 (5.0) | ||
Equivocal | 11/139 (7.9) | 4/11 (36.4) | 4/139 (2.9) | 5/139 (3.6) | 5/5 (100) | 5/139 (3.6) | ||
Positive and equivocal | 46/139 (33.1) | 23/46 (50.0) | 23/139 (16.5) | 12/139 (8.6) | 12/12 (100) | 12/139 (8.6) | ||
Positive | 5/139 (3.6) | 4/5 (80.0) | 4/139 (2.9) | 7/139 (5.0) | 7/7 (100) | 7/139 (5.0) | ||
Equivocal | 4/139 (2.9) | 1/4 (25.0) | 1/139 (0.7) | 1/139 (0.7) | 0/1 (0) | 0/139 (0) | ||
Positive and equivocal | 9/139 (6.5) | 5/9 (55.6) | 5/139 (3.6) | 8/139 (5.8) | 7/8 (87.5) | 7/139 (5.0) |